Astal Laboratories [ASTALLTD] vs Future Retail [FRETAIL] Detailed Stock Comparison

Astal Laboratories

Future Retail
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Astal Laboratories wins in 8 metrics, Future Retail wins in 10 metrics, with 0 ties. Future Retail appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Astal Laboratories | Future Retail | Better |
---|---|---|---|
P/E Ratio (TTM) | 10.16 | -0.04 | Future Retail |
Price-to-Book Ratio | 2.23 | -0.10 | Future Retail |
Debt-to-Equity Ratio | 36.86 | -12.67 | Future Retail |
PEG Ratio | 0.43 | 0.00 | Future Retail |
EV/EBITDA | 7.29 | -5.22 | Future Retail |
Profit Margin (TTM) | 12.33% | -52.09% | Astal Laboratories |
Operating Margin (TTM) | 11.14% | -25.44% | Astal Laboratories |
EBITDA Margin (TTM) | 11.14% | N/A | N/A |
Return on Equity | 24.80% | -291.62% | Astal Laboratories |
Return on Assets (TTM) | 14.09% | -16.76% | Astal Laboratories |
Free Cash Flow (TTM) | $-182.92M | $-1.87B | Astal Laboratories |
1-Year Return | -20.02% | 0.00% | Future Retail |
Price-to-Sales Ratio (TTM) | 1.17 | 0.01 | Future Retail |
Enterprise Value | $940.80M | $154.83B | Future Retail |
EV/Revenue Ratio | 1.24 | 1.83 | Astal Laboratories |
Gross Profit Margin (TTM) | 15.24% | 17.63% | Future Retail |
Revenue per Share (TTM) | $77 | $156 | Future Retail |
Earnings per Share (Diluted) | $8.06 | $-65.16 | Astal Laboratories |
Beta (Stock Volatility) | -0.81 | 0.98 | Astal Laboratories |
Astal Laboratories vs Future Retail Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Astal Laboratories | -0.02% | 4.34% | 4.66% | 8.71% | 3.73% | 9.47% |
Future Retail | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Astal Laboratories | -20.02% | 91.08% | 91.08% | 91.08% | 91.08% | 91.08% |
Future Retail | 0.00% | -41.54% | -97.47% | -98.51% | -98.51% | -98.51% |
News Based Sentiment: Astal Laboratories vs Future Retail
Astal Laboratories
News based Sentiment: MIXED
September brought strong financial results and a successful AGM for Astal Laboratories, signaling positive momentum. However, the persistent negative cash flow from operations introduces a significant risk factor, creating a mixed investment narrative. The combination of growth and ongoing challenges makes this a noteworthy month for investors.
Future Retail
News based Sentiment: NEGATIVE
The month of September was dominated by negative developments for Future Retail, including the rejection of a resolution plan, a large amount of outstanding debt, and a declining stock price. These events collectively signal a worsening financial situation and increased risk for investors.
Performance & Financial Health Analysis: Astal Laboratories vs Future Retail
Metric | ASTALLTD | FRETAIL |
---|---|---|
Market Information | ||
Market Cap | ₹889.93M | ₹1.30B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 1,311,607 | 63,719 |
90 Day Avg. Volume | 452,141 | 21,240 |
Last Close | ₹86.10 | ₹2.28 |
52 Week Range | ₹66.72 - ₹101.37 | ₹2.28 - ₹2.28 |
% from 52W High | -15.06% | 0.00% |
All-Time High | ₹131.70 (Sep 09, 2024) | ₹638.61 (Nov 20, 2017) |
% from All-Time High | -34.62% | -99.64% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.91% | 0.87% |
Quarterly Earnings Growth | 0.24% | 0.87% |
Financial Health | ||
Profit Margin (TTM) | 0.12% | -0.52% |
Operating Margin (TTM) | 0.11% | -0.25% |
Return on Equity (TTM) | 0.25% | -2.92% |
Debt to Equity (MRQ) | 36.86 | -12.67 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹36.75 | ₹-22.51 |
Cash per Share (MRQ) | ₹1.76 | ₹1.85 |
Operating Cash Flow (TTM) | ₹-116,989,000 | ₹-3,108,300,000 |
Levered Free Cash Flow (TTM) | ₹89.25M | ₹-31,895,200,000 |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Astal Laboratories vs Future Retail
Metric | ASTALLTD | FRETAIL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 10.16 | -0.04 |
Forward P/E | N/A | 0.12 |
PEG Ratio | 0.43 | 0.00 |
Price to Sales (TTM) | 1.17 | 0.01 |
Price to Book (MRQ) | 2.23 | -0.10 |
Market Capitalization | ||
Market Capitalization | ₹889.93M | ₹1.30B |
Enterprise Value | ₹940.80M | ₹154.83B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.24 | 1.83 |
Enterprise to EBITDA | 7.29 | -5.22 |
Risk & Other Metrics | ||
Beta | -0.81 | 0.98 |
Book Value per Share (MRQ) | ₹36.75 | ₹-22.51 |
Financial Statements Comparison: Astal Laboratories vs Future Retail
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ASTALLTD | FRETAIL |
---|---|---|
Revenue/Sales | ₹253.27M | ₹28.16B |
Cost of Goods Sold | ₹214.66M | ₹23.19B |
Gross Profit | ₹38.61M | ₹4.97B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹30.38M | ₹-7.30B |
EBITDA | ₹32.14M | ₹-3.10B |
Pre-Tax Income | ₹27.93M | ₹-10.63B |
Income Tax | ₹7.03M | N/A |
Net Income (Profit) | ₹20.90M | ₹-10.63B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ASTALLTD | FRETAIL |
---|---|---|
Cash & Equivalents | ₹17.30M | ₹613.00M |
Total Current Assets | ₹456.39M | ₹97.76B |
Total Current Liabilities | ₹267.71M | ₹141.43B |
Long-Term Debt | ₹4.56M | ₹47.21B |
Total Shareholders Equity | ₹359.95M | ₹-12.21B |
Retained Earnings | ₹107.05M | N/A |
Property, Plant & Equipment | ₹0 | ₹56.51B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ASTALLTD | FRETAIL |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ASTALLTD | FRETAIL |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 1,311,607 | 63,719 |
Average Daily Volume (90 Day) | 452,141 | 21,240 |
Shares Outstanding | 9.83M | 542.28M |
Float Shares | 4.10M | 536.78M |
% Held by Insiders | 0.57% | 0.00% |
% Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Astal Laboratories vs Future Retail
Metric | ASTALLTD | FRETAIL |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |